Cancer patients are living longer due to new and aggressive treatments, yet at sites of skeletal metastasis patients experience significant complications. The dilemma for the physicians is to decide whether the metastatic tumor has weakened the bone such that pathological fracture is imminent. A multi-center, prospective, in-vivo study was conducted to identify significant predictors of physicians' treatment plan for skeletal metastasis based on clinical fracture risk assessments (Mirels score) and the proposed CT-based Rigidity Analysis (CTRA).
Patient follow up resulted in 7 fracture cases, where the CTRA method was 100% sensitive and 90% specific, whereas Mirels method was 71% sensitive and 50% specific. Pain, lesion type and lesion size were significant predictors of the pre-CTRA plan. After providing the CTRA results, physicians changed their plan for 36 patients. CTRA results, pain and primary source of metastasis were significant predictors of post-CTRA plan.
Lesion type and size along with pain level were relevant clinical information that influenced physician's plan for management of metastatic appendicular lesions. Physician's treatment 
